Questions & answers: What treatment data support topiramate in bulimia nervosa and binge eating disorder? What is the drug's safety profile? How is it used in these conditions?

Eating Disorders

Volumn 11, Issue 1, 2003, Pages 71-75

  Kotwal, Renu ^a   McElroy, Susan L ^a   Malhotra, Shishuka ^b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b United Health Network   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CITALOPRAM; FLUOXETINE; FLUVOXAMINE; LAMOTRIGINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SIBUTRAMINE; TOPIRAMATE; VENLAFAXINE; ZONISAMIDE;

ANOREXIA; ANXIETY; ARTICLE; ATAXIA; ATTENTION DEFICIT DISORDER; BINGE EATING DISORDER; BULIMIA; CLINICAL TRIAL; COGNITIVE DEFECT; CONFUSION; DIARRHEA; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG USE; DYSPEPSIA; EVIDENCE BASED MEDICINE; EYE DISEASE; FATIGUE; FLU LIKE SYNDROME; HUMAN; INSOMNIA; MEMORY DISORDER; MYALGIA; NAUSEA; NEPHROLITHIASIS; NERVOUSNESS; NONHUMAN; PARESTHESIA; PSYCHOMOTOR DISORDER; SEDATION; SENSORY DYSFUNCTION; SOMNOLENCE; SPEECH DISORDER; TASTE DISORDER; VERTIGO;

EID: 0038732632     PISSN: 10640266     EISSN: None     Source Type: Journal    
DOI: 10.1080/10640260390167500     Document Type: Article

References (12)

1. Appolinario, J. C., Fontenelle, L. F., Papelbaum, M., Breno, J. R., & Coutinho, W. (2002). Topiramate use in obese patients with binge eating disorder: An open study. Canadian Journal of Psychiatry, 47, 271-273
2. Berlant, J., & van Kammen, D. P. (2002). Open-label topiramate as primary or adjunctive therapy in chronic civilian posttraumatic stress disorder: A preliminary report. Journal of Clinical Psychiatry, 63, 15-20.
3. Chengappa, K. N. R., Gershon, S., & Levine, J. (2001). The evolving role of topiramate among other mood stabilizers in the management of bipolar disorder. Bipolar Disorders, 3, 215-232
4. Felstrom, A., & Blackshan, S. (2002). Topiramate for bulimia nervosa with bipolar II disorder. American Journal of Psychiatry, 159, 1246-1247.
5. Hoopes, S., Reimherr, F., Karvois, D., Rosenthal, N., & Karim, R. (2002, May 22). Topiramate treatment of bulimia nervosa. Abstract presented at the American Psychiatric Association 155th Annual Meeting, Philadelphia, PA, Abstract 7.
6. Langtry, H. D., Gillis, J. C., & Davis, R. (1997). Topiramate: A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of epilepsy. Drugs, 54, 752-773
7. Malhotra, S., & McElroy, S. L. (2002). Medical management of obesity associated with mental disorders. Journal of Clinical Psychiatry, 63 (Suppl. 4), 24-32
8. McElroy, S. L., Arnold, L. M., Shapira, N. A., Keck, Jr., P. E., Rosenthal, N. R., Karim, R., Kamin, M., & Hudson, J. I. (In press). Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial. American Journal of Psychiatry.
9. Reimherr, F. W., Hoopes, S. P., Karvois, D., Karim, R., Kamin, M., & Rosenthal, N. (2002, May 18-23). Topiramate in the treatment of bulimia nervosa: Additional efficacy (abstract). Presented at the American Psychiatric Association 155th Annual Meeting, Philadelphia, PA, NR 474.
10. Richard, D., Ferland, J., LaLonde, J., Samson, P., & Deshaies, Y. (2000). Influence of topiramate in the regulation of energy balance. Nutrition, 16, 961-966
11. Smith, U., Axelsen, M., Hellebö-Johanson, E., Lundgren, B., & Ben-Menachem, E. (2000). Topiramate, a novel antiepileptic drug, reduces body weight and food intake in obesity. Obesity Research, 8, 163
12. Stanley, B. G., Ha, L. H., Spears, L. C., & Dee II, M. G. (1993). Lateral hypothalamic injections of glutamate, kainic acid, D,L-alpha-amino-3-hydroxy-5-methyl-isoxazole propionic acid or N-methyl-D-aspartic acid rapidly elicit intense transient eating in rats. Brain Research, 613, 88-95.